UBS O'Connor’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-151,108
| Closed | -$885K | – | 292 |
|
|
2025
Q1 | $885K | Buy |
151,108
+14,592
| +11% | +$85.5K | 0.03% | 183 |
|
|
2024
Q4 | $1.12M | Buy |
136,516
+29,618
| +28% | +$243K | 0.03% | 213 |
|
|
2024
Q3 | $952K | Buy |
106,898
+16,279
| +18% | +$145K | 0.02% | 278 |
|
|
2024
Q2 | $685K | Buy |
90,619
+23,294
| +35% | +$176K | 0.02% | 339 |
|
|
2024
Q1 | $529K | Sell |
67,325
-22,675
| -25% | -$178K | 0.02% | 325 |
|
|
2023
Q4 | $797K | Buy |
90,000
+46,000
| +105% | +$408K | 0.03% | 291 |
|
|
2023
Q3 | $395K | Hold |
44,000
| – | – | 0.01% | 401 |
|
|
2023
Q2 | $543K | Buy |
+44,000
| New | +$543K | 0.01% | 430 |
|
|
2022
Q4 | – | Sell |
-12,430
| Closed | -$225K | – | 39 |
|
|
2022
Q3 | $225K | Sell |
12,430
-78,109
| -86% | -$1.41M | ﹤0.01% | 805 |
|
|
2022
Q2 | $1.28M | Buy |
+90,539
| New | +$1.28M | 0.01% | 727 |
|